Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Expands By 108.3%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the target of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 27,700 shares, an increase of 108.3% from the September 30th total of 13,300 shares. Based on an average daily volume of 150,600 shares, the short-interest ratio is presently 0.2 days.

Biodexa Pharmaceuticals Stock Down 4.6 %

Shares of Biodexa Pharmaceuticals stock opened at $6.31 on Friday. Biodexa Pharmaceuticals has a 1-year low of $4.71 and a 1-year high of $220.25.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.